A new study from the Kowalinski group at EMBL Grenoble characterized the structure of an important trypanosomal protein ...

A global team has made a significant advance in understanding how bacterial plasmids contribute to antibiotic resistance.

A new study from the Kowalinski group at EMBL Grenoble characterised the structure of an important trypanosomal protein complex, potentially paving the way for novel drug discovery in the future.

An international collaboration has achieved an important breakthrough in understanding the genetic mechanisms that allow bacteria to build resistance to drugs.

Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery. Company also announces ...

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...

To tackle a backlog in toxicity testing, US federal scientists are modernizing programs with high-throughput assays and AI.

The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.